Panagiotis Anagnostis

The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy

Luigi Bartalena, George J. Kahaly, L. Baldeschi et al. · European Journal of Endocrinology · 2021 · 977 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

Vasilios G. Athyros, Thomas Gossios, Theodora Griva et al. · The Lancet · 2010 · 686 citations

Pharmacy, Cardiology, Pharmacotherapy +14

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 305 citations · Full text

Public Health, Endocrinology, Genetics +13

Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions

Panagiotis Anagnostis, John C. Stevenson, David Crook et al. · Maturitas · 2015 · 176 citations

Life Sciences, Biochemistry, Endocrinology +12

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement

Petros Perros, László Hegedüs, Luigi Bartalena et al. · Orphanet Journal of Rare Diseases · 2017 · 170 citations · Full text

Medicine, Dermatology, Endocrinology +6